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Abstract 
Background 
Standard indicators of quality of care have been developed in the United States. Limited 
information exists about quality of care in countries with universal healthcare coverage. 
Objective 
To assess the quality of preventive care and care for cardiovascular risk factors in a country 
with universal healthcare coverage. 
Design and Participants 
Retrospective cohort of a random sample of 1002 patients aged 50-80 years followed for 2 
years from all Swiss University primary care settings. 
Main measures 
We used indicators derived from RAND’s Quality Assessment Tools. Each indicator was 
scored by dividing the number of episodes when recommended care was delivered by the 
number of times patients were eligible for indicators. Aggregate scores were calculated by 
taking into account the number of eligible patients for each indicator. 
Key results 
Overall, patients (44% women) received 69% of recommended preventive care, but rates 
differed by indicators. Indicators assessing annual blood pressure and weight measurements 
(both 95%) were more likely to be met than indicators assessing smoking cessation 
counseling (72%), breast (40%) and colon cancer screening (35%; all p<0.001 for 
comparisons with blood pressure and weight measurements). 83% of patients received 
recommended care for cardiovascular risk factors, including >75% for hypertension, 
dyslipidemia and diabetes. However, foot examination was performed only in 50% of patients 
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with diabetes. Prevention indicators were more likely to be met in men (72.2% vs. 65.3% in 
women, p<0.001) and patients <65 years (70.1% vs. 68.0% in those ≥65 years, p=0.047). 
Conclusions 
Using standardized tools, these adults received 69% of recommended preventive care and 
83% of care for cardiovascular risk factors in Switzerland, a country with universal coverage. 
Prevention indicator rates were lower for women and the elderly and for cancer screening. 
Our study helps pave the way for targeted quality improvement initiatives and broader 
assessment of healthcare in Continental Europe. 
MeSH keywords 
Quality of health care, Insurance coverage, Primary health care, Primary prevention 
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Background 
Standard indicators of the quality of preventive and chronic disease care have been developed 
and evaluated in the United States (US) 1,2. Using RAND’s Quality Assessment (QA) Tools, a 
quality assessment system that spans over 30 conditions and prevention, McGlynn et al. 
found that US adults received 55% of recommended health care services in 12 metropolitan 
areas1. In United Kingdom (UK), a systematic performance monitoring has been introduced in 
2004 coupled with financial incentives3, the Quality and Outcomes Framework (QOF). 
We have limited information about the quality of preventive care in Continental Europe. Most 
previous studies on the quality of preventive care in Europe have assessed only few indicators 
of quality for many conditions4, or one condition at a time, such as hypertension5,6 or 
diabetes7,8. Thus, we have limited data on the quality of preventive care given to adults in 
Continental Europe, particularly using standardized tools. In Switzerland, quality of care has 
been assessed for only a few specific conditions9-11. 
The Swiss and US healthcare systems differ on at least two points. In Switzerland, all patients 
have universal healthcare coverage, including adults with low income who receive social aid 
to cover healthcare costs, regardless of their age or whether they work. Patients are free to 
choose their primary care physician (PCP). Second, systematic performance monitoring and 
annual report cards on quality of care, such as US Healthcare Effectiveness Data and 
Information Set (HEDIS)12, and financial incentives to improve quality, are not implemented 
in Switzerland. While this practice is not universal in the US and in Europe, limited data exist 
on the quality of care in a country without such quality improvement programs. 
We therefore sought to assess the quality of care in Switzerland, using indicators adapted 
from RAND’s QA Tools1. We focused our study on primary and secondary prevention, and 
thus assessed the delivery of preventive care and chronic care for cardiovascular risk factors 
(CVRFs) to 1002 randomly selected adults from all Swiss University primary care settings. 
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Methods 
Study design and Patients 
In a retrospective cohort study, we abstracted medical charts from a random sample of 
patients followed by PCPs in all Swiss University primary care settings (Basel, Geneva, 
Lausanne and Zürich). This study was approved by the Institutional Review Board at each 
site. Most of the care was provided by residents in general internal medicine at the end of 
their postgraduate training (n=902, 90%), supervised by University attendings, while 100 
patients (10%) were followed by University attendings. The random sample was drawn from 
electronic administrative data of all patients aged 50 to 80 years followed in 2005-2006. We 
limited our sample to this age group to have a high enough prevalence of examined indicators 
(e.g. CVRFs, eligibility for cancer screening or influenza immunization). A similar sample 
size was used in previous studies on quality of care based on chart abstraction13,14. 
Among the 1889 patients in the starting random sample identified from electronic 
administrative data, 54 charts could not be found, most likely because the patients left the 
clinical setting for another practice. Compared to included patients, these 54 patients had a 
similar age (63.5 years vs. 64.0, p=0.65) and proportion of women (35% vs. 44%, p=0.22). 
Among the 1835 reviewed medical charts, 591 had <1 year follow-up in the primary care 
clinic during the review period, 125 patients had no outpatient visit to a PCP during the 
review period (emergency visits or nurse appointments only) and 117 were followed in a 
specialized clinic only. We did not include patients who were followed in the clinical setting 
for <1 year to have adequate time and information to assess provided preventive care. The 
final sample included 1002 abstracted medical charts. 
Quality Indicators 
We selected 37 quality indicators from RAND’s QA Tools1,2 concerning preventive care and 
the care of CVRFs. This system was previously developed in the US to evaluate the quality of 
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care delivered to adults15. Briefly, RAND staff physicians reviewed established national 
guidelines and the medical literature for each condition. Chosen indicators focused on 
processes of care, because they represent the activities that clinicians control most directly1. 
Multispecialty expert panels chose the final RAND indicators, using RAND-UCLA modified 
Delphi method16. 
As our aim was to examine care related to primary and secondary prevention, we selected 37 
indicators: 14 for preventive care (physical examination: 3; alcohol: 2; smoking cessation: 5; 
cancer screening: 2; influenza immunization: 2), 19 for chronic care of three major CVRFs 
(hypertension: 4; dyslipidemia: 2; diabetes: 13) and 4 for chronic care for cardiovascular 
disease (Table 2 and 3, unabridged indicators in Appendix Table 1, available online). The 
definitions of hypertension, dyslipidemia and diabetes were adapted from a previous study17 
(Appendix Table 2, available online). We did not include preventive care indicators that were 
not applicable to our local guidelines or PCP settings (e.g. pregnancy follow-up very rarely 
performed by PCPs in Switzerland), to information usually not collected in charts in 
Switzerland, to adults aged 50-80 years, or indicators for conditions of low prevalence in our 
sample (e.g. asthma). Excluded quality indicators are listed at the bottom of Appendix Table 1 
(available online). We included indicators on coronary artery disease, as it is the most 
common cause of death in Switzerland18. 
Chart abstraction 
A chart review was performed for data abstraction, similar to previous studies with direct 
abstraction from medical charts1,13,14,19. A data abstraction form was created to assess the 37 
selected indicators for chronic and preventive care derived from RAND’s QA Tools1 
(Appendix Table 2, available online). Other abstracted covariates (demographics, chronic 
comorbid conditions) were based on a chart abstraction form from the TRIAD study19 
(Translating Research into Action for Diabetes), a study about the quality of diabetes care in 
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US. Nine medical students were centrally trained at one site (Lausanne) for data abstraction 
from medical charts in each Swiss University primary care setting, and then entered the data 
with EpiData software (version 3.1, EpiData Association, Denmark). 
To assess inter-rater reliability, we repeated the chart abstraction on a random sample of 
patients (n=45, to detect a statistically significant kappa20) at one site (Lausanne). Inter-rater 
reliability using the kappa statistic ranged from 0.66 to 1.0 for the main quality indicators, 
consistent with a previous study using a similar method19. The inter-rater reliability was lower 
(0.35 to 0.57) for some indicators that were prone to interpretation (e.g. lifestyle 
modifications for hypertension) or those that required a specific recommended frequency over 
the two years (e.g. eye exam annually, foot exam and HbA1c twice a year for diabetics). As a 
sensitivity analysis, we tested whether the exclusion of indicators with lower inter-rater 
reliability (kappa<0.6) or indicators which are gender-specific (breast cancer screening) 
changed the global aggregate scores. 
Statistical analysis 
For each selected indicator of preventive care and chronic care for CVRFs, we calculated the 
percentage of provided recommended care, by dividing all episodes in which recommended 
care was delivered by the number of times patients were eligible for indicators (overall 
percentage method21). When care was refused by eligible patients, it was counted as provided 
care to measure physician-initiated care. The results were presented as percentages with 95% 
binomial exact confidence intervals (CI). To summarize the selected indicators, we calculated 
aggregate scores of quality of care among the different categories of prevention (physical 
examination, counseling, screening and immunization) and a global aggregate score for 
preventive care. All these aggregate scores were calculated by taking into account the number 
of eligible patients for each selected indicator. The same method of calculation was used to 
obtain the aggregate scores of chronic care for hypertension, dyslipidemia and diabetes, and a 
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global aggregate score for chronic care for CVRFs, summarizing care for these three 
conditions. 
We used generalized estimating equation (GEE) binomial models to compare differences in 
rates of recommended preventive care and to assess the association between demographic 
characteristics (age, gender) and the proportion of provided care. GEE models were used to 
account for correlation of multiple measurements for the same patient and for different 
number of eligible patients for each recommended preventive care. To account for clustering 
by the 4 sites, we treated each primary care center as a fixed effect. For all statistical analyses, 
Stata software (version 10.1, Stata Corp., Texas) was used. 
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Results 
Characteristics of the patients 
The mean age of our sample was 63.5 years with 44% of women and 51% married patients 
(Table 1). 38% of patients were retired and 29% employed. During the two-year review 
period, the median number of outpatient visits was 10 (range 2-63, SD 6.5). The prevalence of 
CVRFs was 75% for hypertension, 62% for dyslipidemia, 29% for diabetes. 23% of the 
participants were current smokers, 36% had a prior cardiovascular disease, 22% a psychiatric 
disorder and 20% a chronic pulmonary disease. 
Analysis of delivered care 
Tables 2 and 3 show the selected indicators, the aggregate scores, the number of eligible 
patients for each indicator and the number of patients who were provided such care. Patients 
received 69% of recommended preventive care, but this result differed by specific indicators. 
Indicators assessing annual blood pressure and weight measurements (both 95%) were more 
likely to be met than indicators assessing alcohol consumption counseling (77%), smoking 
cessation counseling (72%), breast cancer (40%) and colon cancer screening (35%; all 
p<0.001 for comparisons with blood pressure and weight measurements). The level of 
performance according to particular aggregate score ranged from 88% for physical 
examination to 33% for influenza immunization. 
83% of patients received recommended care for CVRFs, including >75% for hypertension, 
dyslipidemia and diabetes. However, glycosylated hemoglobin was measured at least twice a 
year in 72% of diabetics and foot examination was performed twice a year in 50%. Daily 
aspirin was recommended to 95% of patients with coronary artery disease (n=152). Among 
the 60 patients with previous myocardial infarction, beta-blockers were prescribed to 82% of 
patients. 89% of patients received antiplatelet therapy after stroke or transient ischemic attack 
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(n=74) and 89% of patients with heart failure (n=47) an angiotensin-converting enzyme 
inhibitor or an angiotensin-receptor blocker. 
In multivariate analyses adjusted for age, gender and center as a fixed effect, prevention 
indicators were more likely to be met in men (72.2% vs. 65.3% in women, p<0.001) and 
patients <65 years (70.1% vs. 68.0% in those ≥65 years, p=0.047, Figure). Removing the only 
gender-specific indicator (i.e. breast cancer screening) from this analysis yielded similar 
results.  
Adherence rates to chronic care for CVRFs did not differ according to age and gender (both 
p>0.10). Sensitivity analyses excluding two indicators for hypertension and three indicators 
for diabetes, with lower inter-rater reliability (see Methods), yielded a higher aggregate score 
for chronic care of CVRFs (93% vs. 83%). Results for aggregate scores were similar between 
patients followed by residents and University attendings. 
Comparison with other settings 
The rates of recommended preventive care and chronic care for CVRFs in this study were 
compared with similar indicators from US HEDIS 2006 results12, when available (Table 4). 
Overall, quality of care did not differ between the two settings for CVRFs and smoking 
cessation. The major differences were for influenza immunization and breast and colorectal 
cancer screening that were performed far more frequently in the US than in Switzerland. 
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Discussion 
Using standardized indicators developed in the US1, we found that adults in University 
primary care settings received 69% of recommended preventive care and 83% of chronic care 
for CVRFs in Switzerland, a country with universal healthcare coverage but no systematic 
performance monitoring. Women and the elderly had lower receipt of recommended 
preventive care, and rates of cancer screening were low (<40%). 
In the US, several studies have been conducted about the quality of care. McGlynn et al.1 
found that US adults received about 55% of recommended care. The comparison of our 
results with the McGlynn study was limited because that study reported data from 1998-2000. 
The comparison with US HEDIS 2006 results12 yielded a mixed picture (Table 4). 
Interestingly, although the methods of measurement and the studied populations differed 
somewhat between HEDIS12 and our study, quality of care in Swiss University primary care 
settings was comparable to US, except for lower rates of cancer screening and influenza 
immunization in Switzerland, even though there is no systematic performance monitoring, nor 
mandatory annual report cards on quality of care in Switzerland. Our study was not designed 
to assess the reasons of unprovided recommended care, but hypotheses are the lack of 
national campaign for cancer screening, the limited information in media about health issues 
in Switzerland, compared to the US, and the lack of systematic performance monitoring with 
regular feedback (which might improve PCP performance22). An older Swiss study23 found 
similarly low rates of influenza immunization (41% if age <65 years with chronic illness, and 
51% if >65 years), suggesting a lower acceptance of influenza immunization24 than in the US. 
Another study using RAND’s QA Tools showed that quality of care in the US Department of 
Veterans Affairs (VA) was higher than that in the community14. Much of the difference was 
attributable to VA scoring higher in conditions subject to VA performance monitoring. The 
high overall level of care we found may be related to universal coverage or to the specific 
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setting. Indeed, quality of care might have been lower if we had included community-based 
PCP offices outside of University primary care settings, like in US14 or UK25,26 studies. 
To our knowledge, this is the first study to document the quality of a broad range of primary 
and secondary preventive care indicators in Continental Europe. In the UK, the systematic 
performance monitoring known as QOF3 was introduced in 2004. Current published data 
were limited to patients with cardiovascular diseases26 or diabetes25, which may not be 
applicable to the general population. In over a million patients with diabetes followed in 147 
clinics, Calvert et al.25 found higher rates of HbA1c testing (89.3% vs. 71.9% in our study), 
annual eye examination (75.0% vs. 55.8%) or screening for nephropathy (74.1% vs. 65.1%), 
but a lower rate of cholesterol testing (89.7% vs. 97.6%). Other quality indicators on the 
prevention and management of cardiovascular diseases in primary care have been developed 
across nine European countries4, but no data using this new set of indicators have been 
published yet. For Switzerland, no study has been published on the overall quality of 
preventive care, but only on specific conditions9-11. 
Men received more recommended care than women. The gender differences in quality of care 
are consistent with studies on hypertension27, dyslipidemia28, diabetes care29,30 or therapy 
introduced after cardiovascular events31-33. More attention should be placed on preventive 
care for women in Switzerland. 
Patients <65 years received also more recommended care than the elderly, although the 2.1% 
difference was borderline statistically significant and may not be clinically meaningful. The 
lower rate of recommended care among older adults might be related to the higher number of 
indicators for whom older adults became eligible or to lower attention to preventive care. Our 
findings of lower preventive care in the elderly are similar to a previous US study2, but need 
to be confirmed by further research. 
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The higher level of quality of care for CVRFs compared to preventive care might be 
explained by the ease of ordering laboratory tests or prescribing new medications, compared 
to counseling on lifestyle modifications or cancer screening. Counseling might also have been 
subject to more underreport than laboratory tests in medical charts. 
Our study has several limitations. Our data were only abstracted from medical charts with 
potential underreport. A previous study compared process-based quality scores using 
standardized patients, clinical vignettes and abstraction of medical charts and found that 
measurement of quality of care using abstraction of medical charts was about 5% lower than 
using clinical vignettes and 10% lower than using standardized patients34. As influenza 
immunization can be done directly by nurses in Switzerland, we validated the influenza 
immunization indicators with an external administrative register at one site (Lausanne), and 
found that 8% of patients had actually been immunized although this information was not 
reported in the medical chart, a similar rate as in the previous report described above34. 
Another limitation was that some indicators had a lower inter-rater reliability (see Methods). 
Sensitivity analyses excluding these indicators yielded a higher aggregate score for chronic 
care of CVRFs (93% vs. 83%), which might be explained by the lower rates of provided care 
for these indicators with lower kappa statistic. A third limitation was that our data were only 
abstracted in University primary care settings, where almost all patients received their care 
from residents. Aggregate scores were similar for patients followed by residents and 
University attendings, but the proportion of patients followed by University attendings (10%) 
was small for such comparisons. A previous study found a higher adherence to diabetes care 
guidelines by internal medicine residents compared to faculty members35, whereas another 
found similar rates of performance for preventive care between residents and attendings36. 
One study among Swiss community-based PCPs found similar results for diabetes care11 (as 
measured by face-to-face interviews of PCPs) compared to our study. However, we did not 
find studies directly comparing performance between community-based PCPs and University-
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based residents. Therefore, our data may not be generalizable to community-based PCPs. 
Additionally, our study included slightly fewer women in University primary care settings 
than the natural gender ratio of the Swiss general population (44.4% vs. 50.8% of women, 
respectively), which might be related to the fact that many Swiss healthy women are followed 
only by gynecologists. 
In summary, using indicators from RAND’s QA Tools, adults in University primary care 
settings received 69% of recommended preventive care and 83% of chronic care for CVRFs 
in Switzerland, a country without systematic performance monitoring but universal insurance 
coverage. Women and the elderly had lower receipt of recommended preventive care services, 
and cancer screening rates were low. Our findings suggest that, like in the US, there still is 
substantial room for improvement in preventive care delivered to Swiss adults, in particular 
for cancer screening and influenza immunization. Our study may allow to better target future 
quality initiatives in specific areas, and to strengthen the case for broader performance review 
of quality of care across Continental Europe. 
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Table 1. Patients' characteristics: random sample of 1002 adults aged 50-80 years in all 
Swiss University primary care settings 
 
Age 
 Mean, yr (SD) 63.5 (8.3) 
Range, min - max 50 - 80 
Women, no (%) 445 (44.4) 
Civil status, no (%) 
 Married 506 (51.0) 
Divorced, separated 233 (23.5) 
Single 151 (15.2) 
Widow/-er 103 (10.4) 
Occupation, no (%) 
 Retired 372 (37.9) 
Employed 285 (29.0) 
At home, or in education 115 (11.7) 
Social aid 109 (11.1) 
Unemployed, or other 101 (10.3) 
Number of outpatient visits over 2 years 
 Median (Interquartile Range) 10 (7 - 15) 
Range, min - max 2 - 63 
Cardiovascular risk factors 
 Hypertension *, no (%) 753 (75.2) 
Dyslipidemia *, no (%) 622 (62.1) 
Diabetes *, no (%) 292 (29.1) 
Family history of early CHD †, no (%) 99 (9.9) 
Smoking status at baseline ‡, no (%) 
 Former smokers 177 (17.7) 
Current smokers 230 (23.0) 
Comorbid conditions 
 Cardiovascular disease §, no (%) 364 (36.3) 
Chronic pulmonary disease ‖, no (%) 201 (20.1) 
Non-metastatic solid cancer ¶, no (%) 133 (13.3) 
Metastatic solid cancer, no (%) 16 (1.6) 
Hematological cancer, no (%) 10 (1.0) 
Dementia, no (%) 24 (2.4) 
Psychiatric disorders #, no (%) 287 (28.6) 
 
* For criteria of Dyslipidemia, Hypertension and Diabetes, see Appendix Table 2 (available online) 
† Early Coronary Heart Disease (CHD) defined as a CHD event in male relatives < 55 years or in 
female relatives < 65 years  
‡ Smoking status defined as: Former smoker = stopped smoking ≥ 6 months before baseline; current 
smoker = smoking at baseline or stopped < 6 months before baseline 
§ History of transient ischemic attack, cerebral vascular accident, coronary artery disease, angina, 
myocardial infarction, congestive heart failure or peripheral vascular disease ‖ Classification based on Charlson index37: chronic obstructive pulmonary disease (COPD), asthma, 
sleep apnea syndrome, sarcoidosis, pulmonary hypertension, bronchiectases, interstitial pulmonary 
disease or global respiratory insufficiency. 
¶ Includes prostate, colo-rectal, breast, lung, kidney, urothelial, gynecological and other types of 
cancer in the last 5 years. 
# Classification based on Charlson index37: depression, psychotic disorder and bipolar disorder. 
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Table 2. Recommended Preventive Care 
Indicator    
Eligible 
patients 
no 
Care 
provided * 
no 
Care provided 
% (95% CI) 
 Physical examination    
1 Annual blood pressure measurement 1002 952 95.0 (93.5-96.3) 
2 Weight measurement 1002 952 95.0 (93.5-96.3) 
3 Height measurement 1002 753 75.1 (72.4-77.8) 
 Aggregate score for physical examination   88.4 (87.2-89.5) 
 Alcohol consumption counseling    
4 Asked about drinking problem 1002 671 67.0 (64.0-69.9) 
5 Advice to decrease drinking for at risk or binge drinkers † 132 102 77.3 (69.2-84.1) 
 Aggregate score for alcohol consumption counseling     68.2 (65.4-70.9) 
 Smoking cessation counseling    
6 Smoking status documented 1002 789 78.7 (76.1-81.2) 
7 Annual advice to quit smoking 230 165 71.7 (65.4-77.5) 
8 Counseling offered to smokers attempting to quit 77 52 67.5 (55.9-77.8) 
9 Pharmacotherapy offered to smokers attempting to quit if >10 cig./day 77 37 48.1 (36.5-59.7) 
10 Abstinence documented 4 weeks after smoking cessation counseling 52 24 46.2 (32.2-60.5) 
 Aggregate score for smoking cessation counseling   74.2 (71.9-76.4) 
 Cancer screening    
11 Screening for colon cancer (aged 50-80) ‡ 984 345 35.1 (32.1-38.1) 
12 Screening for breast cancer (aged 50-70) ‡ 310 125  40.3 (34.8-46.0) 
 Aggregate score for cancer screening     36.3 (33.7-39.0) 
 Influenza immunization    
13 Annual influenza vaccine for patients ≥ 65 years 426 150 35.2 (30.7-40.0) 
14 Annual influenza vaccine for immunocompromised patients < 65 years § 276 81 29.3 (24.0-35.1) 
 Aggregate score for influenza immunization   32.9 (29.4-36.5) 
 Global aggregate score for Preventive Care   68.6 (67.6-69.7) 
 
* When care was refused by eligible patients, it was counted as provided care to measure physician-
initiated health care. When care was provided less frequently than specified (i.e. once a year instead 
of twice a year, or only once instead of annually), it was counted as unprovided care to measure 
physician adherence to recommendations. 
† At risk drinking was defined as >14 drinks per week for men <65 years or >7 drinks per week for 
others. Binge drinking was defined as >4 drinks per occasion for men <65 years or >3 drinks for 
others. 
‡ Patients were excluded of screening because of a prior diagnosis of colon cancer (n = 18) or breast 
cancer (n = 17) 
§ Indications to influenza immunization for <65 years: living in a nursing home, chronic cardiovascular 
disease, chronic obstructive pulmonary disease, renal failure, diabetes, immunosuppression, 
hemoglobinopathy 
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Table 3. Recommended Chronic Care for Cardiovascular Risk Factors 
Indicator  Chronic care for cardiovascular risk factors  
Eligible 
patients 
no 
Care 
provided * 
no 
Care provided 
% (95% CI) 
 Diabetes       
15 Diabetes documented for patients < 75 years 249 241 96.8 (93.8-98.6) 
16 Glycosylated hemoglobin (HbA1c) twice a year † 292 210 71.9 (66.4-77.0) 
17 Annual eye and visual exam † 292 163 55.8 (49.9-61.6) 
18 Cholesterol tests documented 292 285 97.6 (95.1-99.0) 
19 Annual proteinuria 292 190 65.1 (59.3-70.5) 
20 Foot examination twice a year † 292 147 50.3 (44.5-56.2) 
21 Blood pressure documented 292 291 99.7 (98.1-100.0) 
22 Follow-up visits twice a year 292 259 88.7 (84.5-92.1) 
23 Glucose monitoring for diabetics taking insulin 103 101 98.1 (93.2-99.8) 
24 Dietary and exercise counseling for newly diagnosed diabetics 58 57 98.3 (90.8-100.0) 
25 
Oral hypoglycemics for type 2 diabetics who 
have failed dietary therapy (HbA1c ≥ 7% after 6 
months) 
75 67 89.3 (80.1-95.3) 
26 
Insulin offered to type 2 diabetics who have 
failed oral hypoglycemics (HbA1c ≥ 7% with 2 
oral drugs after 6 months) 
75 54 72.0 (60.4-81.8) 
27 
Angiotensin-converting enzyme inhibitor or 
angiotensin receptor blocker ‡ offered within 3 
months after noting proteinuria or 
microalbuminuria § 
96 85 88.5 (80.4-94.1) 
 Aggregate score for diabetes     79.6 (78.1-81.1) 
 Hypertension    
28 Diagnosis of hypertension when 3 separate visits with blood pressure ≥ 140/90 mmHg 639 614 96.1 (94.3-97.5) 
29 Lifestyle modification for hypertension † 753 485 64.4 (60.9-67.8) 
30 Annual visit for hypertensive patients 753 751 99.7 (99.0-100.0) 
31 
Pharmacotherapy or lifestyle modification for 
uncontrolled hypertension (≥ 140/90 mmHg over 
6 months) † 
502 389 77.5 (73.6-81.1) 
 Aggregate score for hypertension     84.6 (83.2-85.9) 
 Dyslipidemia       
32 Two cholesterol tests before start of therapy 174 154 88.5 (82.8-92.8) 
33 Cholesterol tests if heart disease and no pharmacological therapy 138 134 97.1 (92.7-99.2) 
 Aggregate score for dyslipidemia     92.3 (88.8-95.0) 
 Global aggregate score for care for cardiovascular risk factors     82.6 (81.6-83.6) 
     
 Chronic care for cardiovascular diseases ‖    
34 Aspirin for coronary artery disease 152 144 94.7 (89.9-97.7) 
35 Beta-blockers after acute myocardial infarction 60 49 81.7 (69.6-90.5) 
36 Antiplatelet therapy after stroke or transient ischemic attack 74 66 89.2 (79.8-95.2) 
37 
Angiotensin-converting enzyme inhibitor or 
angiotensin-receptor blocker ‡ for heart failure 
with ejection fraction < 40% 
47 42 89.4 (76.9-96.5) 
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* When care was refused by eligible patients, it was counted as provided care to measure physician-
initiated health care. When care was provided less frequently than specified (i.e. once a year instead of 
twice a year, or only once instead of annually), it was counted as unprovided care to measure physician 
adherence to recommendations. 
† These indicators with lower inter-rater reliability (kappa < 0.6) were excluded in a sensitivity analysis. 
‡ Angiotensin-receptor blocker was added according to Joint National Committee 7th guidelines38 
§ Microalbuminuria was added according to American Diabetes Association guidelines39 ‖ When care was contra-indicated, the patient was not counted as eligible, thus reducing the 
denominator. 
  22 
Table 4. Comparison with Healthcare Effectiveness Data and Information Set (HEDIS)* 
  Switzerland United States * 
Indicator  2005 - 2006 2006 
 Smoking cessation counseling   
7 Annual advice to quit 71.7 73.8 
8 Pharmacotherapy offered to smokers 48.1 43.9 
 Diabetes   
16 HbA1c screening † 71.9 87.5 
17 Annual eye exam screening 55.8 54.7 
18 LDL-cholesterol screening 97.6 83.4 
19 Monitoring nephropathy ‡ 65.1 79.7 
 Cardiovascular disease    
35 Beta blockers a year after heart attack 81.7 72.5 
 Cancer screening   
11 Colorectal cancer 35.2 54.5 
12 Breast cancer § 39.7 72.0 
 Influenza immunization   
13 All patients > 65 years ‖ 35.2 70.3 
14 Potentially immunocompromised < 65 years 29.3 45.6 
 
* Selection of similar indicators on 2006 data from HEDIS12, when available 
† HbA1c screening twice a year in Switzerland, but once a year in US 
‡ Recommended screening for proteinuria in Switzerland, medical attention for kidney disease in US 
§ HEDIS US 2005 rates were reported here as recommended screening age (50-70 years) was the 
same as in Switzerland, instead of 40-70 years (since 2006 in US) ‖ HEDIS US 2005 rates were reported here, because such Medicare data were not available in 2006 
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Figure. Preventive care according to gender (white columns) and age (grey columns) 
See separate file. 
Legend: 
* Adjusted for age and center as a fixed effect 
+ Adjusted for gender and center as a fixed effect 
 
